Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

James C. Foster, CEO of Charles River Laboratories, celebrated the company's five years of public trading by ringing the closing bell at the New York Stock Exchange on June 13.

And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.

A Long Shot on Cytomegalovirus An unlikely vaccinologist fights an unlikely foe. By Alan Dove ARTICLE EXTRAS Developing a hybrid CMV vaccine An economic boost for an unlikely target Two sides or more: from scientist to sculptorSlideshow: the artwork of Gerd MaulPodcast: A vaccine for cytomegalovirusProgress toward combating a rare but costly diseaseGerd Maul was frustrated. It was 1989, and the German-born researcher at Philadelphia's Wistar

A new book explores the impact of equines on early American energy and transportation technology

Commercial kits use fluorescent beads to probe dozens of cytokines in one reaction.

Optical techniques for monitoring action potentials

The list of the year’s best new products contains both perennial winners and innovative newcomers.

When a working map of the human genome was announced in June 2000, it was immediately clear that it would open new avenues of study and transform the life sciences, both in academia and in industry.